Document is current
Any future updates will be listed below
-
Authors
Singh, Meetali https://orcid.org/0000-0002-5783-073X
Chazal, Maxime https://orcid.org/0000-0002-3144-5032
Quarato, Piergiuseppe https://orcid.org/0000-0003-3839-3383
Bourdon, Loan
Malabat, Christophe
Vallet, Thomas https://orcid.org/0000-0001-7775-7448
Vignuzzi, Marco
van der Werf, Sylvie https://orcid.org/0000-0002-1148-4456
Behillil, Sylvie
Donati, Flora https://orcid.org/0000-0003-2862-9751
Sauvonnet, Nathalie https://orcid.org/0000-0003-0306-3376
Nigro, Giulia
Bourgine, Maryline https://orcid.org/0000-0002-8850-8073
Jouvenet, Nolwenn https://orcid.org/0000-0001-6103-6048
Cecere, Germano https://orcid.org/0000-0001-5912-3417
-
Funding
Funding for this research was provided by:
France Génomique (ANR‐10‐INBS‐09‐09)
URGENCE COVID‐19 Institut Pasteur Fundraising Campaign
Pasteur‐Roux‐Cantarini Postdoctoral Fellowship Program
- License Information
-
More Information
Article History
Received: 15 November 2021
Revised: 21 November 2021
Accepted: 6 December 2021
First Online: 16 December 2021
Conflict of interest
: G.C. is an inventor on related CoV2‐miR‐O7a miRNAs European patent application EP 21305192.3 submitted in February 2021. All the other authors declare that they have no conflict of interest.
